Tovorafenib

TAK-580 is a 1,3-thiazolecarboxamide that is 2-[(1R)-1-aminoethyl]-1,3-thiazole-5-carboxylic acid in which the carboxy group undergoes formal condensation with the amino group of 5-chloro-4-(trifluoromethyl)pyridin-2-amine and in which the amino group undergoes formal condensation with the carboxy group of 6-amino-5-chloropyrimidine-4-carboxylic acid. It is a pan-RAF kinase inhibitor that is currently in clinical development for the treatment of radiographically recurrent or progressive low-grade glioma in children and young adults. Among its listed roles, it functions as a antineoplastic agent, an apoptosis inducer and a B-Raf inhibitor. It is a chloropyridine, an organofluorine compound, a secondary carboxamide, an aminopyrimidine, a pyrimidinecarboxamide and a 1,3-thiazolecarboxamide. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tak-580 and OJEMDA. Its PubChem CID is 25161177.

CAS No 1096708-71-2
Molecular Formula C17H12Cl2F3N7O2S
Molecular Weight 506.3 g/mol
Synonyms 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1,3-thiazole-5-carboxamide

Frequently Asked Questions